Johnny Ek

Chief Financial Officer - Akoya Biosciences (Sold to Quanterix, NASDQ: QTRX, in Jul 2025) @ Akoya Biosciences, Inc. Chief Financial Officer (Public / Private) / 4x Strategic M&A / Early Stage to Scale

Phone Number encrypt_section

Education

University of Notre Dame - Mendoza College of Business

Master of Accountancy, Accounting and Finance 2001-01-01 - 2003-01-01

Brigham Young University Marriott School of Business

Bachelors, Finance 1997-01-01 - 2001-01-01

Work Experience

Akoya Biosciences, Inc.

Current

Akoya Biosciences, Inc.

bioMérieux

2021-08-01 - 2023-03-01

bioMérieux

GenMark Diagnostics

2013-11-01 - 2021-08-01

GenMark Diagnostics

eBioscience

2010-10-01 - 2013-11-01

eBioscience

EY

2001-05-01 - 2010-10-01

Bank of America Merrill Lynch

2000-06-01 - 2000-12-01

Bank of America Merrill Lynch

Skills

Sarbanes-Oxley Act US GAAP GAAP SEC filings Revenue Recognition Internal Controls Sarbanes-Oxley Accounting CPA Cost Accounting External Audit Financial Reporting Big 4 General Ledger IPO

Summary

Commercial and operationally focused CFO with 25 years of public and private corporate leadership expertise in strategic sale, capital formation, strategic planning, investor outreach, reporting and analysis, revenue and cost accounting, acquisitions, divestitures, post transaction integration, tax and risk management and internal control implementation and Big Four public accounting experience in the medical device, technology, biotechnology, and Dx industries.

Browse SuperAGI Directories

People Search

1 2 3 4 5 ... 22732309

Company Search

1 2 3 4 5 ... 809223

AI Native CRM for Unified Sales, Support & Marketing Accelerate growth and streamline your entire stack with AI CRM Platform